Sources | Names Used |
---|---|
CTRPv2 | BRD-A02303741:navitoclax (2:1 mol/mol) |
PharmacoGx | BRD-A02303741:navitoclax (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | SF3B4 | CTRPv2 | pan-cancer | AAC | -0.17 | 1e-06 |
mRNA | HSPA4 | CTRPv2 | pan-cancer | AAC | -0.17 | 2e-06 |
mRNA | DEF8 | CTRPv2 | pan-cancer | AAC | -0.17 | 8e-07 |
mRNA | MCL1 | CTRPv2 | pan-cancer | AAC | -0.17 | 9e-07 |
mRNA | CKS1B | CTRPv2 | pan-cancer | AAC | -0.17 | 4e-06 |
mRNA | CCT3 | CTRPv2 | pan-cancer | AAC | -0.17 | 3e-06 |
mRNA | BOLA3 | CTRPv2 | pan-cancer | AAC | -0.17 | 2e-06 |
mRNA | DUS2 | CTRPv2 | pan-cancer | AAC | -0.17 | 3e-06 |
mRNA | NIP7 | CTRPv2 | pan-cancer | AAC | -0.17 | 2e-06 |
mRNA | NFS1 | CTRPv2 | pan-cancer | AAC | -0.17 | 4e-06 |